5-HT1A Antagonist WAY-100635 Prevents Chronic Neurodegeneration and Immune Activation After TBI
Sayanta Dutta, Lilesh Kumar Pradhan, Jie Chen, Nian Wang, Xiang Gao, Arupratan Das
This study shows that WAY-100635, a 5-HT1A antagonist, reduces chronic neurodegeneration and immune activation after TBI by preserving neurons, synapses, and visual function.
bioRxiv · Oct 12, 2026 · PreprintNeuroscience